In clinical trials, ethical standards are more than just rules; they are the foundation of scientific integrity, safety, and ...

Cobenfy (xanomeline and trospium chloride) as an adjunctive treatment to atypical antipsychotics demonstrated a 2.0-point ...

Trials are used to test potential medicines, treatments or procedures. The National Institutes for Health define a clinical ...

KYOTO—Researchers have safely transplanted nerve cells generated from induced pluripotent stem (iPS) cells into the brains of ...

In phase one of its clinical trial, Contraline found that ADAM could successfully block the release of sperm for 24 months, ...

The full abstract will be available on the ASCO® website on May 22, 2025, at 5:00 p.m. ET.

CytoAgents Inc., a clinical-stage biotechnology company developing CTO1681 for the prevention and treatment for Cytokine Release Syndrome (CRS), announced the successful completion of the first dose, ...

Clinical trials show stem cell therapies for Parkinson's disease are safe, potentially offering more effective treatment with ...

In a Phase 1b/2a trial for lymphoma and cytokine release syndrome, the first group's dose-limiting toxicity observation ...

Two clinical trials show that it is safe, but more evidence is needed to prove its effectiveness. Read the paper: Phase I/II trial of iPS-cell-derived dopaminergic cells for Parkinson’s disease ...

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

Stem cell implantation is a step closer to becoming the next strategy against Parkinson's disease. Two clinical trials, one in phase I and the other in phase I/II, have demonstrated their safety and ...